Skip to main content
. 2017 Dec 13;9(13):10962–10977. doi: 10.18632/oncotarget.23493

Figure 2. APE1/Ref-1 redox function specific inhibitors decrease cell number in a concentration dependent manner.

Figure 2

PC-3 (A), C4-2 (B), LNCaP (C) and E7 (D) cell lines were treated with increasing concentrations of redox-specific inhibitor APX3330, more potent analogue APX2009, and inactive analogue RN7-58 for 5 days. The cells were fixed and stained with methylene blue and measured via spectrophotometry. IC25 and IC50 were determined as the concentrations of drug at which there was a 25% and 50% reduction in absorbance compared to vehicle control (DMSO) and were used for subsequent experiments. n = 3. EC50s were compared between the drugs: * denotes p < 0.05 drug EC50 versus RN7-58, while ¶ denotes p < 0.05, APX3330 versus APX2009.